Workshop Date and Time: Wednesday, April 21, 2021, 12:30 – 1:30pm (EDT). AN AUDIO RECORDING IS NOW AVAILABLE! This will be the 8th collaboration between IWMF and CancerCare in a Connect® Education Workshop on WM. CancerCare, is the leading national organization in the U.S. providing free, professional support services and information to help people manage the emotional, practical and financial challenges of cancer.

Topics Covered:

Overview of Waldenstrom’s Macroglobulinemia, including Staging, in the Context of COVID-19
Symptoms & Signs
Front Line Treatment for WM
Treatment for Relapsed/Refractory WM
New Treatment Approaches
Translating Genomic Findings into New Treatment Opportunities for WM
Clinical Trials, in the Context of COVID-19
Controlling Symptoms & Treatment Side Effects, including Reducing Complications
Peripheral Neuropathy
Follow-Up Care
Communicating with Your Health Care Team about Your Quality-of-Life Concerns
Guidelines to Prepare for Telehealth/Telemedicine Appointments
Questions for Our Panel of Experts

Our Panel of Experts:

Stephen Ansell, MD, PhD
Professor of Medicine, Mayo Clinic College of Medicine, Consultant, Division of Hematology, Department of Internal Medicine, Mayo Clinic

Jorge J. Castillo, MD
Clinical Director, Bing Center for Waldenstrom’s Macroglobulinemia, Physician, Dana-Farber Cancer Institute, Associate Professor, Harvard Medical School

Steven Treon, MD, PhD
Director, Bing Center for Waldenstrom’s Macroglobulinemia, Senior Physician, Dana-Farber Cancer Institute, Professor of Medicine, Harvard Medical School

Andrew Branagan, MD, PhD
Attending Physician, Massachusetts General Hospital Cancer Center, Harvard Medical School

Peter DeNardis
IWMF Chair of the Board of Trustees, The International Waldenstrom’s Macroglobulinemia Foundation (IWMF)

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW
Director of Education and Training, CancerCare

Please click the following link to listen to the audio recording of this webcast.